ArticleiScience2024

Zanubrutinib delays selinexor resistance evolution in biopsy sample-derived primary central nervous system lymphoma models.

Xiaohong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.